Navigation Links
Cypak Compliancy Connection Powers Stora Enso Pharma DDSi
Date:11/20/2007

STOCKHOLM, November 20 /PRNewswire/ -- Stora Enso, a leading producer of pharmaceutical packaging boards, has launched Pharma DDSi , the first intelligent pharmaceutical packaging solution to use Cypak's Compliancy Connection.

Compliancy Connection is a standard low-cost electronic module built around a single RFID microchip and is designed to be embedded in pharmaceutical packaging. Electronic sensors are printed onto the packaging to detect when a dose of medicine is removed.

Non-compliance is increasingly recognized as a major problem in health care. Experts believe that over 50% of people do not take their medication as prescribed, causing tens of thousands of avoidable admissions to hospitals and care homes.

There are many reasons for non-compliancy. Memory lapses result in people skipping a dose or even taking multiple doses. Some people worry about side-effects, others misinterpret the instructions on how to take the medication. Sometimes children take medicines that are not intended for them, and older people struggle to open the packaging. Lack of objective compliancy data may even cause doctors to switch medication or increase dosage levels unnecessarily.

Pharma DDSi is a holistic solution that improves compliancy, providing objective data to caregivers and patients alike:

- Electronics embedded in the package provide reminders, record medication events, and transmit the medication history to the care-giver.

- A printed questionnaire captures the patient's feelings when taking medication. Direct communication to a specialist warns of side-effects and enables early intervention.

- DDSi is a carton solution. Clear instructions for use are printed on the packaging.

- Stora Enso also offers child resistant and senior friendly packaging solutions.

Pharma DDSi works with a variety of database solutions including PackAgent Compliance Monitoring software. This system is used for tracking and tracing the packages, capturing the compliance data and sharing results.

Per Nathanaelson, Cypak CEO, comments: "The low-cost electronic solution provided by Cypak, combined with Stora Enso's expertise, is further opening the way for widespread global adoption of intelligent pharmaceutical packaging."

Ismo Saarinen, Director, Pharmaceutical Solutions, Stora Enso, comments: "Pharma DDSi is a ground breaking solution. Together with Cypak we will continue to drive innovation, affordability, and connectivity."

Links: http://www.cypak.com and http://www.storaenso.com/pharma


'/>"/>
SOURCE Cypak AB
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. NIH awards $10.8M to Columbia to study connection between diabetes and heart disease
3. Vitasoy Promotes the Soy Breast Health Connection
4. Randy Jackson and the American Heart Association Promote Awareness about the Connection Between Type 2 Diabetes and Cardiovascular Disease
5. Research examines connection between substance abuse and violence
6. Bestselling Author Dr. Timothy Brantley Explains the Connection of Food and Mood
7. Study finds no connection between vitamin D and overall cancer deaths
8. Free Seminar Features State Funds Back Connection(TM), November 14, in Chico
9. Free Seminar Presents State Funds Back Connection(TM), November 13, in Redding
10. Hormonal Changes and Depression: What is the Connection?
11. Health Knowledge Empowers the Public
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... Each year Standard Process Inc. ... is this year’s Life University winner of a $2,500 scholarship from ... Leadership Awards ceremony. , Outerbridge is approaching her last quarter at Life University ...
(Date:5/26/2016)... ... ... last week’s media reports hinting at a June rate hike after the Federal Reserve’s ... interest rate increase, according to Rajeev Dhawan of the Economic Forecasting Center at Georgia ... (FOMC) dot charts are of interest to the press for their noise potential,” Dhawan ...
(Date:5/26/2016)... ... May 26, 2016 , ... W.S. Badger Co. Inc ., ... with a 2016 When Work Works Award for its use of effective workplace strategies ... When Work Works project administered by the Families and Work Institute (FWI) and the ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... and clinical outcomes, hosted members and suppliers for its inaugural Member Conference at ... on their mission of elevating the operational health of America’s healthcare providers. , ...
(Date:5/26/2016)... Chicago, Illinois (PRWEB) , ... May 26, 2016 , ... ... relationship with women’s basketball as a partner for the Tamika Catchings Legacy Tour ... , As the industry leader in hardwood basketball surfaces in all forms and levels ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... YORK , May 25, 2016  According to ... reached $381 billion in 2015.  Though these are ... plenty of opportunity for success for companies that ... in search of new growth prospects medical device ... on research and development (R&D) than do companies ...
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment of ... doses of biotin in progressive multiple sclerosis: extension phase results ... Ayman Tourbah , Principal Investigator of the Phase 3 study, ... (EAN) in Copenhagen, Denmark . The oral ... Sunday, 29 May 2016 from 14:45 to 16:15 CEST in ...
(Date:5/24/2016)... May 24, 2016   ... beide primären Endpunkte und demonstriert Ebenbürtigkeit ... ‚ausgezeichneter plus guter , ... ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... neue positive Daten von der MORA-Studie der Phase ...
Breaking Medicine Technology: